Skip to main content
Previous Booth
Back to Exhibit
Next Booth

An Alternative LC-MS/MS Fragmentation Approach for Comprehensive Glycopeptide Analysis of Therapeutic Proteins Logo
  • Abstract
  • Resources
  • Authors

Company Biography

The glycosylation profile of biotherapeutics is quite heterogenous, and is a key area that requires multiple methodologies to ensure full characterization as the complexity can pose analytical problems. The CID-based mass spectrometry approach for peptide mapping has continued to have difficulty with glycopeptides as traditional fragmentation techniques do not allow for consistent identification and localization of glycans on peptides. Here, a newly developed dissociation technique that creates MS/MS fragment ions while maintaining the intact glycosylation was evaluated. A second technology called Zeno trap was used in conjunction to enhance the duty cycle for MS/MS fragment ions and improve the overall sensitivity and coverage of peptides. NISTmAb and trastuzumab, 2 humanized IgG1 mAbs, were prepared and digested with trypsin before injection into the LC-MS/MS system for peptide mapping. Data was acquired using data-dependent acquisition on a QTOF system (ZenoTOF 7600 system, SCIEX) with either CID or electron activated dissociation (EAD), a novel type of ExD. The resulting data from both types of acquisition was evaluated by comparing sequence coverage, peptide fragments, oxonium ions and peptide glycan fragments. While sequence coverage using CID and EAD was comparable, major differences were identified in glycosylated peptides. CID showed oxonium ions as being dominant in the spectra, while EAD showed a rich abundance of c- and z-ions, providing full coverage of the peptide backbone. Along with providing full peptide backbone coverage, EAD fragmentation included fragment ions with the intact glycosylation attached, allowing for unambiguous assignment of the location of this modification. This ability to assign location was not only identified on high abundant glycopeptides such as G0F-peptide, but also perpetuated to much lower abundant glycans such as Mannose 5, and the unambiguity of assignment was maintained because of the high-quality fragment ion spectra. Data derived from CID could not provide this level of information.

Contact Information

Name
Zoe Zhang
Address
CA
Email
zoe.zhang@sciex.com

You have chosen to not share your information with An Alternative LC-MS/MS Fragmentation Approach for Comprehensive Glycopeptide Analysis of Therapeutic Proteins
Live chat

Team Members

Zoe Zhang profile image

Zoe Zhang

SCIEX

Presenter
Zoe Zhang
SCIEX
Email: zoe.zhang@sciex.com
Fang Wang profile image

Fang Wang

SCIEX

Co-Author
Fang Wang
SCIEX
Email: fang.wang@sciex.com
Jenny Albernese profile image

Jenny Albernese

SCIEX

Co-Author
Jenny Albernese
SCIEX
Email: Jenny.Albernese@sciex.com
Kerstin Pohl profile image

Kerstin Pohl

SCIEX

Co-Author
Kerstin Pohl
SCIEX
Email: kerstin.pohl@sciex.com
Sibylle Heidelberger profile image

Sibylle Heidelberger

SCIEX UK Ltd.

Co-Author
Sibylle Heidelberger
SCIEX UK Ltd.
Email: Sibylle.heidelberger@sciex.com